September 6, 2021
Nichi-Iko Pharmaceutical said on September 2 that it has completed its share sale to Medipal Holdings under a third-party allotment scheme, making the major wholesaler its largest shareholder with a 9.9% stake. The stake of TAMURA, a company fully owned...read more